Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Reshape Lifesciences Inc's Business Segments

Reshape Lifesciences Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2026
Reportable Segments
2
Per the company's own filing, this quarter
Largest Segment
Pharmaceutical
Total Revenue
$ 0
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/RSLS/segments
https://api.csimarket.com/api/v1/companies/RSLS/geographic
https://api.csimarket.com/api/v1/companies/RSLS/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2026

0%largest
  • Pharmaceutical0%
  • Biotechnology0%

Revenue by Reportable Segment - Q1 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
PharmaceuticalQ1 FY2026$ 0--
BiotechnologyQ1 FY2026-0%-

Revenue by Product & Service Category - Q1 FY2026

79%largest
  • Product79.1%
  • Royalty19%
  • License0%

Revenue by Product & Service Category - Q1 FY2026

CategoryPeriodRevenue
(Millions)
% of Total
ProductQ1 FY2026$ 079.1%
RoyaltyQ1 FY2026$ 019%
LicenseQ1 FY2026-0%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

Description of Reshape Lifesciences Inc

Reshape Lifesciences Inc is a medical technology company that specializes in developing innovative and minimally invasive therapies to address obesity and other metabolic diseases. The company's main focus is on the development and commercialization of a unique gastric balloon system known as ReShape®.

The ReShape® system is a non-surgical, dual balloon system that is designed to help patients lose weight by occupying space in the stomach, thereby reducing its capacity for food intake. The system consists of two connected, medical-grade silicone balloons that are inserted into the stomach through a minimally invasive endoscopic procedure. Once inserted, the balloons are filled with a sterile saline solution, which helps to create a feeling of fullness and satiety, making it easier for patients to adhere to a reduced-calorie diet.

Reshape Lifesciences Inc has developed the ReShape® system to address the needs of patients who are considered overweight or obese and have struggled with traditional weight loss methods such as diet and exercise. The company aims to provide an alternative weight loss solution that is less invasive and provides a shorter recovery time compared to more invasive procedures such as gastric bypass surgery.

In addition to the ReShape® system, Reshape Lifesciences Inc also offers a comprehensive support program to help patients achieve and maintain their weight loss goals. The program includes ongoing coaching, nutritional counseling, and lifestyle modification guidance to ensure long-term success.

The company has conducted extensive clinical trials and research to demonstrate the safety and efficacy of the ReShape® system. These studies have shown significant weight loss and improvements in comorbidities such as hypertension and diabetes in patients who have undergone the procedure.

Reshape Lifesciences Inc is committed to providing healthcare professionals with the necessary training and resources to effectively offer the ReShape® system to their patients. The company offers comprehensive training programs, ongoing support, and marketing materials to help healthcare providers successfully integrate the system into their practice.

The ReShape® system has received regulatory approvals in various countries, including the United States and European Union, further solidifying its credibility and market potential. Reshape Lifesciences Inc continues to expand its market presence by actively seeking partnerships and collaborations with key stakeholders in the healthcare industry.

Overall, Reshape Lifesciences Inc is dedicated to improving the lives of individuals struggling with obesity and metabolic diseases by offering an innovative and patient-friendly approach to weight loss. Through the development and commercialization of the ReShape® system, the company aims to contribute to the global fight against obesity and revolutionize the field of metabolic medicine.
Reshape Lifesciences Inc. is a healthcare company focused on addressing obesity and related metabolic conditions through innovative solutions. The company primarily targets the growing obesity crisis by providing a range of products and services that encompass weight-loss solutions, educational initiatives, and support systems designed to facilitate long-term lifestyle changes.

Segments:

1. Medical Devices: Reshape Lifesciences designs and manufactures medical devices aimed at assisting in weight loss procedures. This segment focuses mainly on minimally invasive options that can help patients achieve lasting results with fewer risks compared to traditional surgical methods.

2. Clinical Services: This segment involves providing clinical support and services related to weight management programs. These services might include consultations, pre- and post-operative care, and ongoing support tailored to individual patient needs.

3. Digital Health Solutions: Reshape Lifesciences also prioritizes the development of digital health platforms that utilize technology to offer personalized weight-loss plans, tracking tools, and patient engagement solutions. This segment may include mobile applications, telehealth services, and online resources that provide education and support.

4. Pharmaceuticals: Though primarily recognized for medical devices, the company may explore partnerships or collaborations to offer pharmacological solutions that adjoin their devices or support their overall approach to weight management.

Products:

1. Reshape Balloon: This is a non-surgical weight loss solution designed to be placed in the stomach, helping patients feel fuller with less food intake. The balloon is typically inserted endoscopically and is intended for individuals who are struggling with obesity and are seeking a temporary aid to jump-start their weight loss journey.

2. ReshapeCare® Program: This integrated program encompasses a comprehensive approach combining medical devices and behavioral therapy. It includes personal coaching, dietician consultations, and ongoing support to help patients adopt healthier lifestyles.

3. Weight Loss Surgery Products: Reshape Lifesciences may also offer a range of surgical solutions or support restorative care for patients opting for bariatric surgery.

4. Supplemental Products: The company may provide nutritional supplements or meal replacement products aimed at supporting patients through their weight loss journeys. These products can complement their other offerings by ensuring patients receive adequate nutrition while managing calorie intake.

Services:

1. Patient Support Programs: Reshape Lifesciences places a strong emphasis on ongoing patient support, offering programs that provide emotional, nutritional, and physical health counseling to ensure individuals remain motivated and informed throughout their weight loss process.

2. Healthcare Provider Training: The company may engage in training healthcare providers on how to effectively implement their products and services, ensuring a streamlined approach for patient care and support.

3. Telehealth Services: Recognizing the importance of accessibility, Reshape Lifesciences likely offers telehealth solutions that allow patients to connect with healthcare professionals remotely, facilitating consultations and follow-ups that align with the modern preference for digital interactions.

4. Community Engagement: The company may focus on building supportive communities through local workshops and seminars, thereby creating networks that encourage shared experiences and motivations among patients.

5. Research & Development Services: To stay at the forefront of obesity treatment, Reshape Lifesciences likely engages in ongoing research to refine existing products and develop new solutions tailored to shifting patient needs and outcomes.

Overall, Reshape Lifesciences Inc. presents a multifaceted and integrated approach to tackling obesity and its associated challenges through a diverse array of medical devices, comprehensive programs, and supportive services. These offerings reflect the company’s commitment to enhancing the quality of life for individuals grappling with obesity and related health complications.